| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |